Evidence map›Paper›PMID 42800835›Full record

ReviewArchives of toxicology2026

Scientific perspectives on in vivo developmental neurotoxicity testing: study design, regulatory context, and future directions.

Pragati S Coder, Richard Lewis, Anika Christoffel, Phil Botham, Richard Bartlett, Megan D'souza, Colin Ehnes, Frank Faulhammer, Susann Fayyaz, Dilshan S Harischandra and 13 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Archives of toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Pragati S CoderCharles River Laboratories, Ashland, OH, USA.ORCID http://orcid.org/0009-0007-4303-6387
Richard LewisRegulatory Science Associates Largs Yacht Haven, Irvine Road, Largs, Scotland, KA30 8EZ, UK.
Anika ChristoffelBASF SE, Ludwigshafen, Germany.
Phil BothamSyngenta, Jealott's Hill, Bracknell, RG42 6EY, UK.
Richard BartlettSyngenta, Jealott's Hill, Bracknell, RG42 6EY, UK.
Megan D'souzaECETOC, Rue Belliard 40, Brussels, 1040 , Belgium. megan.dsouza@ecetoc.org.ORCID https://orcid.org/0009-0005-6267-948X
Colin EhnesBASF SE, APD/ET, Speyerer Strasse 2, Limburgerhof, 67117, Germany.
Frank FaulhammerBASF SE, Global Toxicology & Ecotoxicology, Ludwigshafen, Germany.
Susann FayyazClariant Produkte (Deutschland) GmbH, Industriepark Höchst, Building G 860, Frankfurt am Main, Germany.
Dilshan S HarischandraLabcorp, Greenfield, IN, USA.ORCID http://orcid.org/0000-0003-3220-8765
Parvinder KaurRIFCON GmbH, Goldbeckstraße 13, 69,493, Hirschberg, Germany.
Susanne N KolleBASF, DE SE, Ludwigshafen, Germany.ORCID http://orcid.org/0000-0002-3502-1034
Abby LiExponent Health Sciences, Menlo Park, California, USA.
Jason MantonToxiqua Ltd, Worcester, UK.ORCID http://orcid.org/0000-0002-0707-1368
Benoît NihoulDow Silicone Belgium, Rue Jules Bordet, 7180, Seneffe, Belgium.
Heidrun PotschkaInstitute of Pharmacology, Toxicology, and Pharmacy, Ludwig-Maximilians-Universität, Munich, Germany.ORCID http://orcid.org/0000-0003-1506-0252
Emily RichmondExponent International, Harrogate, UK.ORCID http://orcid.org/0000-0003-4843-1697
Martijn RooseboomShell Global Solutions International B.V., The Hague, The Netherlands.ORCID http://orcid.org/0000-0002-6054-2886
Eddie SloterThe Lubrizol Corporation, Wickliffe, OH, US.
Lorna F TempestHuntsman Surface Sciences UK, Cambridge, UK.ORCID http://orcid.org/0009-0001-6736-1738
Abigail ToltinCorteva Agriscience, Indianapolis, IN, USA.ORCID http://orcid.org/0000-0003-0086-6245
Corina van den HeuvelCharles River Laboratories, 's-Hertogenbosch, The Netherlands.
Matthew WolterS.C. Johnson & Son, Inc, Racine, WI, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Developmental neurotoxicity (DNT) potential of (agro)chemicals is assessed in rodents according to OECD Test Guidelines (TG) 426 (DNT) or 443 (Extended One-Generation Reproductive Toxicity; EOGRTS) incorporating a DNT cohort. While the EOGRTS evaluates reproductive and neurotoxicity endpoints across multiple life stages, key differences in study design, dose selection, and exposure duration between OECD 426 and OECD 443 can complicate data interpretation and impact hazard identification and risk assessment. This manuscript evaluates current DNT testing strategies and examines the feasibility of a combined DNT-EOGRTS approach aimed at generating data for regulatory decision making. This combined approach requires substantial modifications to the EOGRTS design, and its implementation should be approached with caution. Given the increased complexity and logistical challenges, additional cognitive assessments such as learning and memory (L&M) should only be included when scientifically justified on a substance specific basis. Retrospective analyses indicate that L&M is among the least sensitive DNT endpoints, and its inclusion in an EOGRTS does not yield a functional equivalent of a standalone DNT. The review also examines regulatory triggers and recent regulatory decisions relevant to inclusion of cognitive assessments. Finally, the status and limitations of alternative approaches, including the in vitro DNT battery and zebrafish embryo models, are discussed. Overall, OECD 426 remains the scientifically preferred approach for DNT assessment. While a combined design may be feasible, it is inherently suboptimal for DNT evaluation. Collectively, this comprehensive review provides recommendations for generating robust DNT data while supporting animal welfare-conscious, future-oriented regulatory testing strategies.

Indexed as

Developmental neurotoxicityDNT in vitro batteryEOGRTSLearning and memoryNew approach methodsOECD 426OECD 443

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.